期刊文献+
共找到985篇文章
< 1 2 50 >
每页显示 20 50 100
Improving the accuracy and consistency of clinical target volume delineation for rectal cancer by an education program 被引量:2
1
作者 Yang-Zi Zhang Xiang-Gao Zhu +7 位作者 Ma-Xiaowei Song Kai-Ning Yao Shuai Li Jian-Hao Geng Hong-Zhi Wang Yong-Heng Li Yong Cai Wei-Hu Wang 《World Journal of Gastrointestinal Oncology》 SCIE 2022年第5期1027-1036,共10页
BACKGROUND Accurate target volume delineation is the premise for the implementation of precise radiotherapy.Inadequate target volume delineation may diminish tumor control or increase toxicity.Although several clinica... BACKGROUND Accurate target volume delineation is the premise for the implementation of precise radiotherapy.Inadequate target volume delineation may diminish tumor control or increase toxicity.Although several clinical target volume(CTV)delineation guidelines for rectal cancer have been published in recent years,significant interobserver variation(IOV)in CTV delineation still exists among radiation oncologists.However,proper education may serve as a bridge that connects complex guidelines with clinical practice.AIM To examine whether an education program could improve the accuracy and consistency of preoperative radiotherapy CTV delineation for rectal cancer.METHODS The study consisted of a baseline target volume delineation,a 150-min education intervention,and a follow-up evaluation.A 42-year-old man diagnosed with stage IIIC(T3N2bM0)rectal adenocarcinoma was selected for target volume delineation.CTVs obtained before and after the program were compared.Dice similarity coefficient(DSC),inclusiveness index(IncI),conformal index(CI),and relative volume difference[ΔV(%)]were analyzed to quantitatively evaluate the disparities between the participants’delineation and the standard CTV.Maximum volume ratio(MVR)and coefficient of variation(CV)were calculated to assess the IOV.Qualitative analysis included four common controversies in CTV delineation concerning the upper boundary of the target volume,external iliac area,groin area,and ischiorectal fossa.RESULTS Of the 18 radiation oncologists from 10 provinces in China,13 completed two sets of CTVs.In quantitative analysis,the average CTV volume decreased from 809.82 cm3 to 705.21 cm3(P=0.001)after the education program.Regarding the indices for geometric comparison,the mean DSC,IncI,and CI increased significantly,whileΔV(%)decreased remarkably,indicating improved agreement between participants’delineation and the standard CTV.Moreover,an 11.80%reduction in MVR and 18.19%reduction in CV were noted,demonstrating a smaller IOV in delineation after the education program.Regarding qualitative analysis,the greatest variations in baseline were observed at the external iliac area and ischiorectal fossa;61.54%(8/13)and 53.85%(7/13)of the participants unnecessarily delineated the external iliac area and the ischiorectal fossa,respectively.However,the education program reduced these variations.CONCLUSION Wide variations in CTV delineation for rectal cancer are present among radiation oncologists in China's Mainland.A well-structured education program could improve delineation accuracy and reduce IOVs. 展开更多
关键词 Rectal cancer RADIOTHERAPY clinical target volume DELINEATION Interobserver variation EDUCATION
下载PDF
Reducing intrathecal pressure after traumatic spinal cord injury: a potential clinical target to promote tissue survival 被引量:2
2
作者 Anna V Leonard Robert Vink 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第3期380-382,共3页
Spinal cord injury (SCI) is an unexpected event that is both devastating and debilitating, resulting in not just motor and sensory loss, but also autonomic dysfunction of the bladder, bowel and sexual organs. Curren... Spinal cord injury (SCI) is an unexpected event that is both devastating and debilitating, resulting in not just motor and sensory loss, but also autonomic dysfunction of the bladder, bowel and sexual organs. Currently, there are no treatments available to improve outcome follow- ing SCI, leaving individuals with permanent and lifelong physical disability. Worldwide it is estimated that more than 500,000 people sustain a SCI each year, with average lifetime cost of paraplegia and quadriplegia estimated at $5 million and $9.5 million respectively. We therefore urgently need effective therapies to improve quality of life following SCI, and this requires a greater understanding of how cell and axonal injury develops after the traumatic event. 展开更多
关键词 ITP TBI a potential clinical target to promote tissue survival Reducing intrathecal pressure after traumatic spinal cord injury SCI
下载PDF
Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation 被引量:10
3
作者 Wen-Fei Li Ying Sun +7 位作者 Mo Chen Ling-Long Tang Li-Zhi Liu Yan-Ping Mao Lei Chen Guan-Qun Zhou Li Li Jun Ma 《Chinese Journal of Cancer》 SCIE CAS CSCD 2012年第12期579-587,共9页
Clinical target volume (CTV) delineation is crucial for tumor control and normal tissue protection. This study aimed to define the locoregional extension patterns of nasopharyngeal carcinoma (NPC) and to improve CTV d... Clinical target volume (CTV) delineation is crucial for tumor control and normal tissue protection. This study aimed to define the locoregional extension patterns of nasopharyngeal carcinoma (NPC) and to improve CTV delineation. Magnetic resonance imaging scans of 2366 newly diagnosed NPC patients were reviewed. According to incidence rates of tumor invasion, the anatomic sites surrounding the nasopharynx were classified into high-risk (>30%), medium-risk (5%-30%), and low-risk (<5%) groups. The lymph node (LN) level was determined according to the Radiation Therapy Oncology Group guidelines, which were further categorized into the upper neck (retropharyngeal region and level Ⅱ), middle neck (levels Ⅲ and Va), and lower neck (levels Ⅳ and Vb and the supraclavicular fossa). The high-risk anatomic sites were adjacent to the nasopharynx, whereas those at medium- or low-risk were separated from the nasopharynx. If the high-risk anatomic sites were involved, the rates of tumor invasion into the adjacent medium-risk sites increased; if not, the rates were significantly lower (P < 0.01). Among the 1920 (81.1%) patients with positive LN, the incidence rates of LN metastasis in the upper, middle, and lower neck were 99.6% , 30.2%, and 7.2%, respectively, and skip metastasis happened in only 1.2% of patients. In the 929 patients who had unilateral upper neck involvement, the rates of contralateral middle neck and lower neck involvement were 1.8% and 0.4%, respectively. Thus, local disease spreads stepwise from proximal sites to distal sites, and LN metastasis spreads from the upper neck to the lower neck. Individualized CTV delineation for NPC may be feasible. 展开更多
关键词 鼻咽癌 局部区域 靶区 临床 圈定 解剖部位 磁共振成像 肿瘤学
下载PDF
Cancer stem cell impact on clinical oncology 被引量:6
4
作者 Mariel E Toledo-Guzmán Gabriele D Bigoni-Ordonez +1 位作者 Miguel Ibanez Hernandez Elizabeth Ortiz-Sánchez 《World Journal of Stem Cells》 SCIE CAS 2018年第12期183-195,共13页
Cancer is a widespread worldwide chronic disease. In most cases, the high mortality rate from cancer correlates with a lack of clear symptoms, which results in late diagnosis for patients, and consequently, advanced t... Cancer is a widespread worldwide chronic disease. In most cases, the high mortality rate from cancer correlates with a lack of clear symptoms, which results in late diagnosis for patients, and consequently, advanced tumor disease with poor probabilities for cure, since many patients will show chemo-and radio-resistance. Several mechanisms have been studied to explain chemo-and radio-resistance to anti-tumor therapies, including cell signaling pathways, anti-apoptotic mechanisms, stemness, metabolism, and cellular phenotypes. Interestingly, the presence of cancer stem cells(CSCs), which are a subset of cells within the tumors, has been related to therapy resistance. In this review, we focus on evaluating the presence of CSCs in different tumors such as breast cancer, gastric cancer, lung cancer, and hematological neoplasias, highlighting studies where CSCs were identified in patient samples. It is evident that there has been a great drive to identify the cell surface phenotypes of CSCs so that they can be used as a tool for anti-tumor therapy treatment design. We also review the potential effect of nanoparticles, drugs, natural compounds, aldehyde dehydrogenase inhibitors, cell signaling inhibitors, and antibodies to treat CSCs from specific tumors. Taken together, we present an overview of the role of CSCs in tumorigenesis and how research is advancing to target these highly tumorigenic cells to improve oncology patient outcomes. 展开更多
关键词 CANCER targetED THERAPY clinical OUTCOME DRUG resistance CANCER stem cells
下载PDF
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials 被引量:1
5
作者 Wenlin Chen Delin Liu +4 位作者 Penghao Liu Ziren Kong Yaning Wang Yu Wang Wenbin Ma 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2021年第3期417-432,共16页
Recurrence is a major concern for adult patients with glioblastomas(GBMs), and the prognosis remains poor.Although several therapies have been assessed, most of them have not achieved satisfactory results. Therefore, ... Recurrence is a major concern for adult patients with glioblastomas(GBMs), and the prognosis remains poor.Although several therapies have been assessed, most of them have not achieved satisfactory results. Therefore, there is currently no standard treatment for adult recurrent GBM(r GBM). Here, we review the results of clinical trials for the systematic therapy of r GBM. Regorafenib, rindopepimut and neoadjuvant programmed death 1(PD-1)inhibitors are promising agents for r GBM, while regorafenib is effective in both O6-methylguanine DNA methyltransferase(MGMT) promoter methylated and unmethylated patients. Temozolomide rechallenge and alkylating agents combined with bevacizumab can be useful for patients with MGMT methylation, and patients with isocitrate dehydrogenase(IDH) mutations or second recurrence can benefit from vocimagene amiretrorepvec(Toca511). Some phase I trials on targeted therapy and immunotherapy have shown positive results, and results from further studies are expected. In addition to the analysis of existing clinical trial results, forthcoming trials should be well designed, and patients are encouraged to participate in appropriate clinical trials. 展开更多
关键词 Recurrent glioblastoma systematic therapy clinical trial targeted therapy IMMUNOTHERAPY
下载PDF
Clinical nutrition in the hepatogastroenterology curriculum
6
作者 Chris JJ Mulder Geert JA Wanten +5 位作者 Carol E Semrad Palle B Jeppesen Hinke M Kruizenga Nicolette J Wierdsma Matthijs E Grasman Adriaan A van Bodegraven 《World Journal of Gastroenterology》 SCIE CAS 2016年第5期1729-1735,共7页
Gastroenterology(GE) used to be considered a subspecialty of internal medicine. Today, GE is generally recognized as a wide-ranging specialty incorporating capacities, such as hepatology, oncology and interventional e... Gastroenterology(GE) used to be considered a subspecialty of internal medicine. Today, GE is generally recognized as a wide-ranging specialty incorporating capacities, such as hepatology, oncology and interventional endoscopy, necessitating GEexpert differentiation. Although the European Board of Gastroenterology and Hepatology has defined specific expertise areas in Advanced endoscopy, hepatology, digestive oncology and clinical nutrition, training for the latter topic is lacking in the current hepatogastroenterology(HGE) curriculum. Given its relevance for HGE practice, and being at the core of gastrointestinal functioning, there is an obvious need for training in nutrition and related issues including the treatment of disease-related malnutrition and obesity and its associated metabolic derangements. This document aims to be a starting point for the integration of nutritional expertise in the HGE curriculum, allowing a central role in the management of malnutrition and obesity. We suggest minimum endpoints for nutritional knowledge and expertise in the standard curriculum and recommend a focus period of training in nutrition issues in order to produce well-trained HGE specialists. This article provides a road map for the organization of such a training program. We would highly welcome the World Gastroenterology Organisation, the European Board of Gastroenterology and Hepatology, the American Gastroenterology Association and other(inter)national Gastroenterology societies support the necessary certifications for this item in the HGE-curriculum. 展开更多
关键词 GASTROENTEROLOGY Training clinical nutrition MALNUTRITION Metabolism CURRICULUM targeted therapy ENTERAL FEEDING PARENTERAL FEEDING Obesity
下载PDF
Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer-clinician's insight 被引量:3
7
作者 Andrzej M Bugaj 《World Journal of Methodology》 2016年第1期65-76,共12页
Vascular targeted photochemotherapy(VTP) holds promise as a novel strategy of the focal treatment of localised prostate cancer(LPCa). It is convenient to perform, minimally invasive and can be conduct in ambulatory co... Vascular targeted photochemotherapy(VTP) holds promise as a novel strategy of the focal treatment of localised prostate cancer(LPCa). It is convenient to perform, minimally invasive and can be conduct in ambulatory conditions. In this review, methodologic aspects of padoporfin- and padeliporfin-mediated VTP and its clinical application in focal treatment of LPCa as well as future perspective of this method were presented. Physicochemical and pharmacokinetic parameters of padoporphin and padeliporfin using as VTP photosensitizers were described, as well as methodologic question of radiation delivery and dosimetry, and oxygen monitoring in cancer tissue in context of VTP safety and efficiency of LPCa focal therapy were discussed. The results of clinical trials concerning application of padoporfin- and padeliporfin-mediated VTP in LPCa were also presented. The future of VTP is development of protocols, founded on the realtime feedback and rules-based approach to make this strategy a standard procedure in LPCa treatment. To evaluate clinical potential of this procedure, a costeffectiveness analysis is also necessary. 展开更多
关键词 Localised PROSTATE cancer FOCAL therapy Vascular-targeted PHOTOCHEMOTHERAPY Methodology clinical trials
下载PDF
Thinking and practice on clinical safety evaluation of combination of traditional Chinese medicine and western medicine
8
作者 Rui Zheng Zhao Chen +4 位作者 Chen Zhao Xiao-Yu Zhang Ming-Yue Ma Yang Sun Hong-Cai Shang 《TMR Modern Herbal Medicine》 CAS 2022年第4期24-27,共4页
China is gradually establishing a multidisciplinary diagnosis and treatment system of traditional Chinese medicine(TCM)and western medicine.TCM-drug combination is prone to adverse reactions.Clinical feature is the ap... China is gradually establishing a multidisciplinary diagnosis and treatment system of traditional Chinese medicine(TCM)and western medicine.TCM-drug combination is prone to adverse reactions.Clinical feature is the appearance of adverse reactions,and target is the internal mechanism.The establishment of feature and target correlation model will contribute to the development of this field.This paper introduces the four steps of feature-target correlation method that risk identification,feature extraction,sign target correlation and experimental research.Xiyanping-Ribavirin combination is as an example to illustrate this method.It is expected that the method will be popularized and applied to protect clinical safety. 展开更多
关键词 Safety TCM-drug combination clinical feature target Feature-target correlation method
下载PDF
AccuLearning自动勾画临床靶区和危及器官用于宫颈癌术后放疗的可行性研究 被引量:1
9
作者 陈飞 龚筱钦 +4 位作者 余云鹏 游涛 王旭 戴春华 胡静 《实用医学杂志》 CAS 北大核心 2024年第2期153-157,共5页
目的从几何学和剂量学探讨AccuLearning(AL)建立宫颈癌术后临床靶区(CTV)和危及器官(OARs)自动勾画模型应用于临床的可行性。方法选取75例宫颈癌术后手动勾画CT数据,60例应用AL训练生成自动勾画模型,并对剩余15例进行自动勾画,同时将自... 目的从几何学和剂量学探讨AccuLearning(AL)建立宫颈癌术后临床靶区(CTV)和危及器官(OARs)自动勾画模型应用于临床的可行性。方法选取75例宫颈癌术后手动勾画CT数据,60例应用AL训练生成自动勾画模型,并对剩余15例进行自动勾画,同时将自动勾画图像上的放疗计划导入到手动勾画结构上,比较两种勾画方式的效率、戴斯相似系数(DSC)、豪斯多夫距离(HD)和剂量学差异。结果自动勾画时间明显小于手动勾画(P<0.05);各结构DSC值≥0.87;肠袋和直肠的HD值在10 mm左右,其余结构小于5 mm;剂量学评估CTV(D98、V90%、V95%、Dmean、HI)、肠袋(V50)和膀胱(V50)有显著性差异(P<0.05)。结论基于AL形成的宫颈癌术后自动勾画模型提高了放疗效率,OARs具有直接应用于临床的可能性,CTV仍需进一步修改。 展开更多
关键词 自动勾画 宫颈癌 临床靶区 危及器官 剂量学
下载PDF
CXCR2在食管癌组织中的表达及其对食管癌细胞生物学行为的影响 被引量:1
10
作者 黄丛改 刘清 +5 位作者 郑树涛 刘涛 谭依依 彭天元 陈娇 卢晓梅 《癌变.畸变.突变》 CAS 2024年第1期53-57,65,共6页
目的:探讨CXC受体2(CXCR2)在食管鳞癌组织中的表达及其对食管癌细胞生物学行为的影响。方法:收集手术切除的食管鳞癌组织74例作为研究组,其配对的癌旁正常食管组织74例作为对照组,采用免疫组织化学染色检测CXCR2的表达,比较研究组与对... 目的:探讨CXC受体2(CXCR2)在食管鳞癌组织中的表达及其对食管癌细胞生物学行为的影响。方法:收集手术切除的食管鳞癌组织74例作为研究组,其配对的癌旁正常食管组织74例作为对照组,采用免疫组织化学染色检测CXCR2的表达,比较研究组与对照组间CXCR2表达水平的差异,分析CXCR2表达及其与临床病理特征的关系。并采用CCK-8试剂盒、平板集落形成实验、细胞迁移和侵袭实验检测CXCR2拮抗剂SCH527123对食管癌细胞KYSE30生物学行为的影响。结果:与对照组比较,CXCR2在食管鳞癌研究组中的阳性表达率为73.0%(54/74),明显高于对照组13.5%(10/74),差异具有统计学意义(χ^(2)=53.298,P=0.000)。CXCR2的表达与食管鳞癌分化程度和淋巴结转移密切相关(χ^(2)=5.515,P=0.019;χ^(2)=7.320,P=0.007);与患者性别、年龄、肿瘤部位、肿瘤大体分型、肿瘤直径、浸润深度、脉管瘤栓及神经侵犯均无明显相关关系(P>0.05)。在体外细胞实验中,与对照组相比,CXCR2拮抗剂SCH527123显著抑制食管癌细胞KYSE30的增殖、迁移和侵袭(均为P<0.05)。结论:CXCR2在食管鳞癌组织中表达上调且与患者的不良预后相关,CXCR2拮抗剂SCH527123可以抑制食管癌细胞的增殖、迁移和侵袭,推测CXCR2可能是食管癌潜在的预测和靶向治疗的分子标志物。 展开更多
关键词 CXCR2 食管癌 临床意义 病理特征 靶向治疗 生物学行为
下载PDF
重构本草——栀子 被引量:1
11
作者 马晶 孙郡 +2 位作者 沈梦菲 胡诗宛 仝小林 《吉林中医药》 2024年第1期87-89,共3页
通过古籍文献调研、中医药现代研究成果的梳理,结合中医临床及中药学等学科领域内知名专家学者的认识及应用经验,归纳出栀子:功效主要为泻火除烦,清热利湿,凉血解毒,外用消肿止痛。症靶为心烦、黄疸。标靶为高血糖。现代药理发现栀子及... 通过古籍文献调研、中医药现代研究成果的梳理,结合中医临床及中药学等学科领域内知名专家学者的认识及应用经验,归纳出栀子:功效主要为泻火除烦,清热利湿,凉血解毒,外用消肿止痛。症靶为心烦、黄疸。标靶为高血糖。现代药理发现栀子及其有效成分具有抗炎解热、保肝利胆、保护神经、降血糖、降血脂、镇痛等作用。栀子具有肝肾毒性,栀子苷是主要的肝毒性成分,临床中应避免长期大剂量服用,同时注意合理配伍。临床使用剂量为3~30 g,内服时当根据不同疾病,或同一疾病的不同阶段进行辨证使用,并积极探索栀子用量与症靶、标靶的量效关系构建。 展开更多
关键词 栀子 症靶 标靶 重构本草 临床回归
下载PDF
基于TARGET数据库儿童急性髓系白血病临床特征分析及基因预后预测模型建立
12
作者 付伟 程国彬 +4 位作者 丁瑶 代芳 蒋艳 邓娅婕 罗永婧 《中国小儿血液与肿瘤杂志》 CAS 2023年第2期81-86,92,共7页
目的本研究旨在分析儿童急性髓系白血病(AML)临床特点及采用临床标记物和常用指标建立预后诺模图。方法选取TARGET(Therapeutically Applicable Research To Generate Effective Treatments)有完整随访的患者437例,按自动随机抽取等比... 目的本研究旨在分析儿童急性髓系白血病(AML)临床特点及采用临床标记物和常用指标建立预后诺模图。方法选取TARGET(Therapeutically Applicable Research To Generate Effective Treatments)有完整随访的患者437例,按自动随机抽取等比例分为建模组(n=308)和验证组(n=129)。采用R统计软件包进行单因素回归分析、Cox回归模型筛选临床变量,设计预后诺模图,并应用一致性指数(C指数)、校准曲线评估诺模图的性能。结果回归分析中提示独立的存活因子包括绿色瘤(Chloroma)P=0.001、t(8;21)染色体易位P=0.0076、t(6;11)(q27;q23)染色体易位P=0.0298、16号染色体短臂长臂倒位(inv16)P=0.0115、单倍体7(monosomy 7)P=0.0003、WT1突变P=0.0310、危险度分层(Risk group)P=0.0131。生存分析显示monosomy 7,Risklevel,inv(16)对生存影响较大(P<0.05)。建模组验证中的诺模图C指数为0.696,验证组中的诺模图C指数为0.743。总生存期的3年ROC曲线为0.682,(95%CI为0.600~0.734),5年ROC曲线为0.693(95%CI为0.599~0.739)。结论绿色瘤(Chloroma)、t(8;21)染色体易位、t(6;11)(q27;q23)染色体易位、16号染色体短臂长臂倒位(inv16)、单倍体7(monosomy 7)、WT1突变、危险度分层(risk group)可作为儿童AML生存预后判断的独立指标。基于筛选变量建立的诺模图模型,有可能成为儿童AML预后判断的重要预测模型。 展开更多
关键词 急性髓性白血病 target数据库 诺模图 临床特征 预后模型
下载PDF
槐耳颗粒联合分子靶向药物治疗脾虚型原发性肝癌的临床疗效 被引量:1
13
作者 石功亮 何勇 颜艳倩 《西部医学》 2024年第1期120-124,共5页
目的 探讨槐耳颗粒联合分子靶向药物治疗脾虚型原发性肝癌(PHC)的临床疗效及对肝功能、免疫功能的影响。方法 回顾性分析2020年1月—2021年12月本院收治的PHC患者70例,按就诊先后顺序分为A组和B组各35例。两组患者均实施常规支持治疗。... 目的 探讨槐耳颗粒联合分子靶向药物治疗脾虚型原发性肝癌(PHC)的临床疗效及对肝功能、免疫功能的影响。方法 回顾性分析2020年1月—2021年12月本院收治的PHC患者70例,按就诊先后顺序分为A组和B组各35例。两组患者均实施常规支持治疗。A组在常规治疗上使用分子靶向药物治疗,B组在A组的基础上联合槐耳颗粒治疗,两组患者皆进行4周的治疗。对两组治疗前后中医证候积分、生活质量、肝功能及免疫功能指标的变化实施观察,并评价两组临床疗效与安全性。结果 B组总有效率(97.14%)显著高于A组(80.00%)(P<0.05)。治疗前,两组中医症候积分比较,差异无统计学意义(P>0.05);两组中医症候积分在治疗后均降低,且B组积分低于A组(P<0.05);治疗前,两组患者的CD8^(+)、CD4^(+)和CD4^(+)/CD8^(+)比较,差异无统计学意义(P>0.05);治疗后,两组患者的CD8^(+)、CD4^(+)水平较治疗前显著降低;B组CD4^(+)/CD8^(+)水平较治疗前提高,A组CD4^(+)/CD8^(+)水平较治疗前降低,且B组的CD8^(+)水平低于A组,CD4^(+)与CD4^(+)/CD8^(+)水平高于A组(P<0.05)。治疗前,两组的AST、ALT和TBIL水平比较,差异无统计学意义(P>0.05);治疗后两组AST、ALT和TBIL水平显著减少(P<0.05),且B组明显低于A组(P<0.05)。B组不良反应发生率(11.42%)高于A组(8.57%),但两组高血压、手足综合征、皮疹、恶心呕吐及腹泻等不良反应比较,差异无统计学意义(P>0.05)。治疗后两组生活质量均上升,且B组生活质量优于A组(P<0.05)。结论 槐耳颗粒联合分子靶向药物治疗PHC患者疗效确切,可减轻患者临床症状,改善患者的肝功能以及免疫功能指标,安全性较高,可在临床推广。 展开更多
关键词 槐耳颗粒 分子靶向药物 脾虚型PHC 临床疗效 肝功能 免疫功能
下载PDF
黄芩咳喘散治疗支气管哮喘临床研究和网络药理学效应机制探讨
14
作者 许伟英 孙永宁 +4 位作者 王子杨 刘美志 屠艳婕 曹燕 折哲 《现代中医药》 CAS 2024年第5期51-61,共11页
目的基于网络药理学研究黄芩咳喘散防治支气管哮喘的有效性及其效应物质探讨。方法选取符合纳入标准的患者共94例,随机分为治疗组和对照组各47例。所有患者均接受常规药物治疗。治疗组给予黄芩咳喘散三伏贴,对照组给予其模拟剂三伏贴。... 目的基于网络药理学研究黄芩咳喘散防治支气管哮喘的有效性及其效应物质探讨。方法选取符合纳入标准的患者共94例,随机分为治疗组和对照组各47例。所有患者均接受常规药物治疗。治疗组给予黄芩咳喘散三伏贴,对照组给予其模拟剂三伏贴。对比两组患者治疗前后中医症候积分评分情况、ACT评分、半年内疾病发作次数、血清嗜酸性粒细胞(EOS)等情况。基于网络药理学和分子对接等探讨黄芩咳喘散与支气管哮喘可能的效应物质及作用机制。结果数据显示:①治疗组患者临床治疗总有效率高于对照组(P<0.05);②治疗组患者咳嗽气促、喘息咯痰、食少便溏、神疲乏力单项症状评分、ACT评分、半年内疾病发作次数均低于对照组(均P<0.05);③两组患者EOS水平均降低,且治疗组各指标值明显低于对照组(均P<0.05);④网络药理学筛选黄芩咳喘散有效活性成分潜在作用靶点与支气管哮喘的交集靶点26个,关键有效成分包括四羟基黄酮、亚油酸乙酯、棕榈酸等,涉及核心靶点包括SIRT1、STAT3、ESR1、PPARA等,可能涉及免疫、脂肪酸代谢、激素类反应、细胞坏死因子反应等生物过程。⑤分子对接显示黄芩咳喘散中有效活性成分四羟基黄酮(5,7,2′,6′-Tetrahydroxyflavone)通过氢键分别与支气管哮喘关键靶点SIRT1的氨基酸ILE411、GLU410、LYS408、SER370、LYS375,与STAT3的氨基酸ASP334、LYS574,与ESR1的氨基酸LEU346及PPARA的氨基酸MET320、LEU331、THR334结合。结论黄芩咳喘散治疗支气管哮喘肺脾气虚证患者具有可靠的临床疗效,在改善临床症状、减少疾病发作次数等具有积极作用。经网络药理学分析黄芩咳喘散可能通过SIRT1、STAT3、ESR1等靶点作用于PI3K-Akt、JAK-STAT、NF-κB等通路从减轻气道炎症反应、抑制气道重塑等方面发挥治疗作用,进一步分子对接后提示该药的有效活性成分四羟基黄酮与哮喘疾病靶点SIRT1、STAT3、ESR1及PPARA具有良好的结合能力。 展开更多
关键词 黄芩咳喘散 支气管哮喘 临床疗效 网络药理学靶点 分子对接
下载PDF
目标教学法结合PDCA循环在呼吸科规培护士临床教学中的应用
15
作者 徐小萍 刘巧 洪跃玲 《中国继续医学教育》 2024年第14期63-68,共6页
目的探讨目标教学法结合计划(plan)、执行(do)、检查(check)和处理(act)(PDCA)管理模式在呼吸内科规培护士临床教学中的应用价值。方法选取2021年1月—2022年12月进入呼吸内科轮转的64名规培护士作为研究对象,根据入科时间分为对照组和... 目的探讨目标教学法结合计划(plan)、执行(do)、检查(check)和处理(act)(PDCA)管理模式在呼吸内科规培护士临床教学中的应用价值。方法选取2021年1月—2022年12月进入呼吸内科轮转的64名规培护士作为研究对象,根据入科时间分为对照组和试验组,各32名。对照组采用传统临床教学模式,试验组采用目标教学法结合PDCA管理临床教学模式。对比2组规培护士的考核评分、出科综合素质评分及满意度评分。结果试验组的操作成绩[(96.05±1.57)分],高于对照组[(94.91±1.51)分],差异有统计学意义(P<0.05)。试验组规培护士的沟通协调、专业知识、专业技能、安全意识、解决问题应急能力评分高于对照组,差异均有统计学意义(P<0.05)。试验组满意度平均分为(92.31±1.31)分,高于对照组的(91.07±0.59)分,差异有统计学意义(P<0.05)。结论目标教学法结合PDCA管理临床教学模式有助于提高呼吸内科规培护士的临床操作水平,利于高素质护理人才的培养,同时提升了规培护士的满意度。 展开更多
关键词 目标教学法 计划 执行 检查 处理 呼吸内科 护理规范化培训 临床护理教学 教学效果
下载PDF
仑伐替尼联合PD-1单抗及GEMOX方案在晚期胆道恶性肿瘤治疗中的临床观察
16
作者 邬晓敏 方益鹏 +2 位作者 章真 章烨 金成 《临床荟萃》 CAS 2024年第5期408-412,共5页
目的探讨靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨+奥沙利铂)在胆道恶性肿瘤复发转移患者中的临床效果和安全性。方法选择2015年1月到2024年1月在我院中西医结合肿瘤科及肝胆外科接受靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨... 目的探讨靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨+奥沙利铂)在胆道恶性肿瘤复发转移患者中的临床效果和安全性。方法选择2015年1月到2024年1月在我院中西医结合肿瘤科及肝胆外科接受靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨+奥沙利铂)方案的复发转移的晚期胆道恶性肿瘤患者24例,主要观察终点设置为总体生存期(overall survival,OS)和无进展生存时间(progression-free survival,PFS),次要观察终点设置为客观缓解率(ORR)、疾病控制率(DCR)、安全性。借助肿瘤标记物(CEA、CA125、CA199)变化、不良反应、生活质量评分,影像学改变等各项数据综合评估靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨+奥沙利铂)方案治疗晚期胆道恶性肿瘤复发转移的安全性和整体临床效果。结果部分缓解(PR)8例,稳定(SD)8例,进展(PD)8例,ORR 33.3%(8/24),DCR 66.7%(16/24),中位OS 13个月,中位PFS 8个月。治疗后CA199水平明显低于治疗前(P<0.05)。主要不良反应为皮疹(14/24,58.3%)、白细胞下降(22/24,91.6%)、贫血(20/24,83.3%),其中有1例因严重不良事件退出治疗,1例患者在治疗期间死于胆道梗阻合并感染。结论采用靶免(仑伐替尼+信迪利单抗)联合GEMOX(吉西他滨+奥沙利铂)方案治疗晚期胆道恶性肿瘤复发转移患者具有较高的安全性和有效性,可以在临床使用。 展开更多
关键词 胆道肿瘤 复发转移 化疗 靶向 免疫 临床应用
下载PDF
重构本草——白芍 被引量:3
17
作者 赵旌屹 马凯乐 +5 位作者 张伟 苟筱雯 田佳星 宋斌 王涵 李敏 《长春中医药大学学报》 2024年第1期16-19,共4页
通过对古籍文献记载、中医药现代研究成果的梳理,结合中医学及中药学等学科领域内知名专家学者的认识及临床应用经验,归纳出白芍:功效主要为养血敛血、柔肝止痛、平抑肝阳。症靶为腹痛、肌肉痉挛、胁痛。现代药理学研究揭示,白芍及其有... 通过对古籍文献记载、中医药现代研究成果的梳理,结合中医学及中药学等学科领域内知名专家学者的认识及临床应用经验,归纳出白芍:功效主要为养血敛血、柔肝止痛、平抑肝阳。症靶为腹痛、肌肉痉挛、胁痛。现代药理学研究揭示,白芍及其有效成分白芍总苷具有抗炎、解痉、镇痛、抑菌、通便、缓解急性肝损伤以及调节免疫等功效。白芍及其主要成分白芍总苷的长期毒性实验,未发现对人体和动物的毒性,安全范围大。临床使用剂量为6~120 g,内服时应根据不同疾病或同一疾病的不同阶段进行辨证使用,并积极探索白芍用量与症靶的量效关系构建。 展开更多
关键词 白芍 症靶 重构本草 临床回归
下载PDF
重构本草——龙骨 被引量:2
18
作者 沈梦菲 赵林华 +5 位作者 张伟 林潼 张湘苑 金籽杉 胡诗宛 黄晓巍 《长春中医药大学学报》 2024年第3期252-254,共3页
通过古籍文献调研、中医药现代研究成果的梳理,结合中医临床及中药学等学科领域内知名专家学者的认识及应用经验,归纳出龙骨:功效主要为镇惊安神,平肝潜阳,收敛固涩。症靶为汗出过多、遗精、失眠。现代药理研究发现龙骨及其有效成分具... 通过古籍文献调研、中医药现代研究成果的梳理,结合中医临床及中药学等学科领域内知名专家学者的认识及应用经验,归纳出龙骨:功效主要为镇惊安神,平肝潜阳,收敛固涩。症靶为汗出过多、遗精、失眠。现代药理研究发现龙骨及其有效成分具有中枢抑制和骨骼肌松弛作用,能调节机体免疫功能,有利于消除溃疡和促进伤口的恢复,有镇静催眠、抗抑郁、抗痉厥、促进血液凝固、降低血管通透性等作用。临床使用剂量为15~120 g,内服时当根据不同疾病,或同一疾病的不同阶段进行辨证使用,并积极探索龙骨用量与症靶、标靶的量效关系构建。过敏体质者慎用龙骨。 展开更多
关键词 龙骨 症靶 标靶 重构本草 临床回归
下载PDF
重构本草——黄连 被引量:1
19
作者 张伟 康梦娇 +4 位作者 苟筱雯 汪选斌 张博荀 赵林华 李丽静 《吉林中医药》 2024年第4期467-470,共4页
通过古籍文献调研、中药现代研究进展及其研究成果的梳理,结合中医临床及中药学等学科领域专家学者的认识及应用经验,经讨论认为黄连功效主要为清热燥湿,泻火解毒。症靶为腹泻、呕吐、疮疡肿痛。标靶为高血糖、幽门螺杆菌阳性、心动过... 通过古籍文献调研、中药现代研究进展及其研究成果的梳理,结合中医临床及中药学等学科领域专家学者的认识及应用经验,经讨论认为黄连功效主要为清热燥湿,泻火解毒。症靶为腹泻、呕吐、疮疡肿痛。标靶为高血糖、幽门螺杆菌阳性、心动过速。现代药理研究发现黄连及其有效成分具有抗病原微生物、抗炎、止泻、降糖、抑制幽门螺旋杆菌阳性、抑制房颤、降血脂、抗肿瘤等作用。本品毒性低,但是阴虚烦热、胃虚呕恶、脾虚泄泻、五更泄泻患者慎服。临床使用剂量为1~120 g,内服时当根据不同疾病,或同一疾病的不同阶段进行辨证使用,并积极探索黄连用量与症靶、标靶的量效关系构建。 展开更多
关键词 黄连 症靶 标靶 重构本草 临床回归
下载PDF
重构本草——知母 被引量:1
20
作者 丁齐又 仝小林 +3 位作者 胡诗宛 张伟 康梦娇 赵林华 《吉林中医药》 2024年第4期471-474,共4页
通过古籍文献调研、中药现代研究成果的梳理,结合中医临床及中药学等学科领域内专家学者的认识及应用经验,经讨论认为:知母功效主要为清热泻火,滋阴润燥。症靶为发热、口渴、烦扰不宁、肺热燥咳。标靶为血糖升高。现代药理发现知母及其... 通过古籍文献调研、中药现代研究成果的梳理,结合中医临床及中药学等学科领域内专家学者的认识及应用经验,经讨论认为:知母功效主要为清热泻火,滋阴润燥。症靶为发热、口渴、烦扰不宁、肺热燥咳。标靶为血糖升高。现代药理发现知母及其有效成分具有解热、抗炎、抗病原微生物、降糖、改善气道炎症、缓解肺纤维化、镇静催眠、调节交感神经、抗肿瘤、降血脂等作用。本品苦寒滋腻而质滑,凡脾胃虚寒,寒湿内停,大便溏泄者忌服。临床使用剂量为6~90 g,大剂量使用时,须注意避免知母苦寒损伤脾胃,可配伍生姜、干姜、草果、肉桂等辛温药物,并积极探索知母用量与症靶、标靶的量效关系。 展开更多
关键词 知母 症靶 标靶 临床回归
下载PDF
上一页 1 2 50 下一页 到第
使用帮助 返回顶部